Collegium Pharmaceutical PE ratio COLL

Share price divided by earnings per share over the last twelve months, since 2020.

Today, Oct 23, 2026: 18.5×
6-year median: 19.1×
Against its 6-year history: 46th; percentile: 0 is its lowest day, 100 its highest
6-year range: 6.5× to 223×
Peer median: 10.8×

Collegium Pharmaceutical's PE ratio is 18.5× as of Oct 23, 2026: a share price of $22.96 against $1.24 of earnings per share over the last twelve months.

That is below its 6-year median of 19.1×, close to the middle of its last 6 years.

Over that time it ranged from 6.5× in Aug 2021 to 223× in Feb 2024.

The median for 10 large drugmakers of a similar size is 10.8×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	18.5×	16.4×	29.6×
2025	31.0×	12.6×	37.6×
2024	12.5×	12.5×	223×
2023	205×	163×	205×
2022	19.3×	6.7×	20.6×
2021	7.1×	6.5×	51.3×
2020	40.9×	37.8×	40.9×

Against its peers

Companies in Drug Manufacturers - General nearest Collegium Pharmaceutical's size, closest first, today.

Company	PE ratio
COLLCollegium Pharmaceutical	18.5×
ABUSArbutus Biopharma	5.4×
CRMDCorMedix	3.7×
ZVRAZevra Therapeutics	10.5×
IRWDIronwood Pharmaceuticals	4.5×
PBYIPuma Biotechnology	21.2×
AMPHAmphastar Pharmaceuticals	14.8×
ARVNArvinas	45.6×
OMEROmeros	10.9×
PCRXPacira BioSciences	104×
ANABAnaptysbio	10.7×
Peer median	10.8×

Where Collegium Pharmaceutical ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Collegium Pharmaceutical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.